Based on the prior studies that HOXA‐AS2 is implicated in inflammation‐linked cancers,29, 30, 31 we suggested that HOXA‐AS2 regulates the osteogenic differentiation via mediating NF‐κB activity. Here, NFKB1 is linked to cancer.